beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Parry, A, Corkill, R, Blamire, A, Palace, J, Narayanan, S, Arnold, D, Styles, P, Matthews, P
Μορφή:	Journal article
Έκδοση:	2002

Παρόμοια τεκμήρια

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
ανά: Parry, A, κ.ά.
Έκδοση: (2003)

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.
ανά: Lee, M, κ.ά.
Έκδοση: (2000)

Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.
ανά: Reddy, H, κ.ά.
Έκδοση: (2000)

Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy.
ανά: Blamire, A, κ.ά.
Έκδοση: (2007)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
ανά: Sørensen, P, κ.ά.
Έκδοση: (2010)

Interferon beta treatment of multiple sclerosis.
ανά: Markovitz, D
Έκδοση: (1994)

Axonal loss in the optic nerve and tract in multiple sclerosis
ανά: Esiri, M, κ.ά.
Έκδοση: (2000)

Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability.
ανά: De Stefano, N, κ.ά.
Έκδοση: (2002)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
ανά: Sibley, W, κ.ά.
Έκδοση: (1994)

Protein co-expression with axonal injury in multiple sclerosis plaques.
ανά: Diaz-Sanchez, M, κ.ά.
Έκδοση: (2006)

Treatment of multiple sclerosis with interferon beta-1 b.
ανά: Abdul-Ahad, A, κ.ά.
Έκδοση: (1997)

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
ανά: Evangelou, N, κ.ά.
Έκδοση: (2000)

Axonal injury in reverse.
ανά: Craner, M, κ.ά.
Έκδοση: (2011)

Treatment of multiple sclerosis with interferon beta-1b - Reply
ανά: Sibley, W, κ.ά.
Έκδοση: (1997)

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
ανά: Clerico, M, κ.ά.
Έκδοση: (2008)

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
ανά: Clerico, M, κ.ά.
Έκδοση: (2008)

Axonal injury in cerebral malaria.
ανά: Medana, I, κ.ά.
Έκδοση: (2002)

The evidence for primary axonal loss in multiple sclerosis
ανά: Anthony, D, κ.ά.
Έκδοση: (2000)

[The evidence for primary axonal loss in multiple sclerosis]
ανά: Anthony, D, κ.ά.
Έκδοση: (2000)

Axon damage and repair in multiple sclerosis.
ανά: Perry, V, κ.ά.
Έκδοση: (1999)

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.
ανά: Evangelou, N, κ.ά.
Έκδοση: (2000)

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
ανά: Lampasona, V, κ.ά.
Έκδοση: (2003)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
ανά: Ebers, G, κ.ά.
Έκδοση: (1997)

Axonal buckling following stretch injury
ανά: Lang, G, κ.ά.
Έκδοση: (2017)

The contribution of demyelination to axonal loss in multiple sclerosis
ανά: DeLuca, G, κ.ά.
Έκδοση: (2006)

The contribution of demyelination to axonal loss in multiple sclerosis.
ανά: DeLuca, G, κ.ά.
Έκδοση: (2006)

Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability.
ανά: Reddy, H, κ.ά.
Έκδοση: (2002)

Functional brain reorganization for hand movement in patients with multiple sclerosis: Defining distinct effects of injury and disability
ανά: Reddy, H, κ.ά.
Έκδοση: (2002)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
ανά: Ebers, G, κ.ά.
Έκδοση: (1998)

Altered cellular metabolism following traumatic brain injury: a magnetic resonance spectroscopy study.
ανά: Garnett, MR, κ.ά.
Έκδοση: (2001)

Interferons in relapsing remitting multiple sclerosis.
ανά: Goodin, D
Έκδοση: (2003)

Systemic interferon alfa in multiple sclerosis.
ανά: Weinshenker, BG, κ.ά.
Έκδοση: (1989)

Abnormal cerebral blood volume in regions of contused and normal appearing brain following traumatic brain injury using perfusion magnetic resonance imaging.
ανά: Garnett, MR, κ.ά.
Έκδοση: (2001)

INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL
ανά: Duquette, P, κ.ά.
Έκδοση: (1995)

Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.
ανά: Cader, S, κ.ά.
Έκδοση: (2007)

Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
ανά: Clerico, M, κ.ά.
Έκδοση: (2005)

Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
ανά: Clerico, M, κ.ά.
Έκδοση: (2006)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis
ανά: Petkau, A, κ.ά.
Έκδοση: (2004)

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model
ανά: Vergo, S, κ.ά.
Έκδοση: (2011)

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
ανά: Vergo, S, κ.ά.
Έκδοση: (2011)